Cite
HARVARD Citation
Duffy, E. et al. (2021). Regulatory Action to Protect Access to Hydroxychloroquine for Approved Rheumatic Indications During COVID‐19 in New Zealand. Arthritis & rheumatology. 73 (5), pp. 896-897. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Duffy, E. et al. (2021). Regulatory Action to Protect Access to Hydroxychloroquine for Approved Rheumatic Indications During COVID‐19 in New Zealand. Arthritis & rheumatology. 73 (5), pp. 896-897. [Online].